Search by :
|
With the flu season in full swing, Clinical Labs of Hawaii would
like to remind all providers of our current test options.
|
|
|
Effective November 14, 2016, the Cancer Antigen 15-3 assay is
being performed on the Roche COBAS and as a result, the reference
range has been updated.
|
|
|
Unfractionated Heparin Testing is now available on Maui.
|
|
|
Explanation of HMSA's precertification process
|
|
|
On September 1, 2016, Medicare published an updated version of
its statutorily excluded Molecular Diagnostic (MolDx) tests. This
bulletin provides an explanation and instructions on how to access
this list.
|
|
|
Expanded collection sites now available for the H.pylori Breath
Test.
|
|
|
The Film Array Meningitis/Encephalitis Panel is an FDA approved,
comprehensive, multiplex molecular assay which accurately detects
multiple organisms, including viruses, all on a single, minimal
volume CSF specimen.
|
|
|
The CDC issued a health advisory, travel advisory, and an early
release MMWR concerning Zika virus and its potential impact on
pregnant women, fetuses, and infants. If clinically
indicated, serum evaluation by RT-PCR for nucleic acid
amplification is recommended. Testing is performed at the
State Department of Health and can be ordered via CLH.
|
|
|
All Dengue testing is performed at DOH until further notice. All
requests for Dengue should be submitted with the attached DOH form
customized for Clinical Labs of Hawaii. Attached is the revised DOH
form (revised 1/2016) to include residential address.
|
|
|
Test Update: N-Methyl-D-Aspartate (NMDA) Receptor Antibody now
performed at our West location.
|
|